Jove
Visualize
Contact Us

Related Experiment Videos

Following patients under treatment for hyperprolactinemia.

R W Rebar1

  • 1Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Ohio, USA.

The Journal of Reproductive Medicine
|January 29, 2000
PubMed
Summary

Treatment for hyperprolactinemia varies based on pituitary lesion presence and pregnancy desire. Dopamine agonists are generally effective, with specific management for expectant mothers and those with macroadenomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2002
Same author

Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women.

Menopause (New York, N.Y.)·2001
Same author

Increased coronary events, HERS, and HRT: any connection?

Archives of internal medicine·2001
Same author

Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?

Menopause (New York, N.Y.)·1999
Same author

Delayed puberty in girls and primary amenorrhea.

Current therapy in endocrinology and metabolism·1997
Same author

Combination oral contraceptives.

Current therapy in endocrinology and metabolism·1997
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Endocrinology
  • Neuroscience

Background:

  • Hyperprolactinemia management is complex, influenced by pituitary lesion status (none, microadenoma, macroadenoma) and reproductive goals.
  • Asymptomatic hyperprolactinemia may allow for expectant management with regular monitoring.

Purpose of the Study:

  • To outline a structured approach to managing hyperprolactinemia.
  • To differentiate treatment strategies based on patient-specific factors.

Main Methods:

  • Categorization of patients based on pituitary lesion size and presence.
  • Consideration of patient's desire for pregnancy in treatment planning.
  • Utilizing dopamine agonists as a primary medical therapy.
  • Identifying criteria for neurosurgical referral.

Main Results:

  • Dopamine agonist therapy is effective for most hyperprolactinemia cases.
  • Management strategies are tailored to lesion type and pregnancy intentions.
  • Expectant management is an option for asymptomatic patients.
  • Neurosurgical intervention is reserved for refractory macroadenomas with mass effect.

Conclusions:

  • Personalized management plans are crucial for effective hyperprolactinemia treatment.
  • Dopamine agonists represent a cornerstone of medical therapy.
  • Careful consideration of reproductive status and lesion characteristics guides therapeutic decisions.

Related Experiment Videos